HIGHLIGHTS
- who: Yea-Huei Kao Yang from the febuxostat, allopurinol, gout, difference, TaiwanChung Shan Medical University have published the research: Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients, in the Journal: (JOURNAL)
- what: The authors aimed to divide patients into high and low CV risk groups. The study provided valuable information to illustrate the HF hospitalizations risk of febuxostat use as stratified by low or high CV risk in the Asian population.
- how: The authors identified a study cohort aged >20 years who had used CV-related drugs . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.